http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-718556-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40beb9749591f58ec9dd0bcc66cf1a4b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b25c5322812b57f193f93c056b8243 |
| publicationDate | 2022-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CH-718556-A1 |
| titleOfInvention | In Vitro Drug Allergy Test Procedure |
| abstract | The present invention relates to a method for the in vitro determination of disorders and diseases that are induced by a test substance, in particular a drug. The method includes the step of providing a blood sample, isolating agranulocytes from the blood sample and culturing the agranulocytes with at least one test substance. There is a simultaneous quantitative measurement of a large number of cytokines and/or cytotoxic molecules. The cultivation is carried out with starting cell densities between 3 × 10 5 cells per 0.2 ml and 8 × 10 5 cells per 0.2 ml. The present invention also relates to the use of cell output density for the foregoing. |
| priorityDate | 2021-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 331.